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1. Introduction
Henriette Roscam Abbing was one of the first legal scholars to acknowl-
edge the close relationship between health and human rights, I an issue
that has inspired her-and others-until today." Building on her national,
European and international experience in the field of health law and health
policy she has extensively written on the challenges which developments
in the field of science and their application within and outside the health
care sector can pose for human rights." At the same time, she has zeal-
ously and indefatigably alerted national, European and international pol-
icy makers, legislators, fellow scholars and the public at large to the
detrimental health impacts resulting from (other) human rights violations.
In this respect, she has always been particularly concerned about the adverse
health impacts of violations of privacy rights (e.g. breaches of confidentiality,
non-compliance with the principle of informed consent and other measures
infringing on individual liberty)" and discrimination on such irrelevant fac-
tors as (prospective) health status with respect to health care, employment
and necessary insurances.! Her approach was commonly future-oriented:
what are the likely effects of the current developments in medical science
1 H.D.C. Roscam Abbing, International Organizations in Europe and the Right to Health Care
(Deventer, Kluwer, 1979).
2 H.D.C. Roscam Abbing, 'Health, Rights of the Patient and Patient Participation', in:
H.D.C. Roscam Abbing, K.F. Bopp (eds.), Health, Ethics and Human Rights. 77ze Council of
Europe Meeting the Challenge (Strasbourg, Council of Europe, 2005), pp. 141-164.
3 H.D.C. Roscam Abbing, 'Medische technologische vooruitgang, kans of vooruitgang
voor het recht op de persoonlijke levenssfeer' (Henk Leenen lezing), 28 Tzjdschrift voor
Gezondheidsredu 5-2004, 347-352.
4 H.D.C. Roscam Abbing, 'AIDS, Human Rights and the Legislator in the Netherlands',
in: M. Breum, A.C. Hendriks (eds.), AIDS and Human Rights. An International Perspective
(Copenhagen, Akademisk Forlag, 1988), pp. 96-104.
s H.D.C. Roscam Abbing, 'Recht op gezondheidszorg: een beschouwing over grenzen
].KM. Gevers, E.H. Hondius and].H. Hubben (Eds.), Health Law, Human Rights and the Biomedicine
Convention, 207-218.
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on the enjoyment of human rights? It should come as no surprise that the
progress made in the field of predictive medicine, notable genetics, has
been closely scrutinised by Roscam Abbing."
From the above one could get the impression that Roscam Abbing was
one-sidedly concerned about negative liberty/ as reflected in rights that
seek to guarantee individuals the right to live their own lives free from
outside intrusion." This is everything but true. In her work she paid con-
siderable attention to the obligations of the State to ensure that individu-
als can indeed make their own informed choices and decisions with respect
to health care and other social goods and services." These duties coincide
with positive liberty or, in the terminology of the European Court of
Human Rights (ECtHR), positive State obligations which are known to
extend to the field of health care.!" In addition to examining both nega-
tive and positive freedom rights, Roscam Abbing has stressed the impor-
tance of finding a fair and proper balance between (individual) liberty and
(collective) solidarity, particularly with respect to access to scarce social
goods and services, such as health care.1I Here her underlying thesis has
always been that individual liberty can not be at the expense of such pre-
cious principles as equality and solidarity.
Efforts to strike a fair balance between individual liberty and collective
solidarity go back to the French Revolution. Liberti, egaliti, fratemiti (ou La
mort!) was not just the slogan of the revolutionaries, but reflected the recog-
nition of liberty-inspired civil and political rights and solidarity-based social
en grenzen aan het stellen van grenzen', in: ].K.M. Gevers, ].H. Hubben (eds.), Grenzen
aan de zorg; zorgen aan de grens (Liber Amicorum voor prof dr. HJJ. Leenen) (Alphen aan
den Rijn, Samsom H.D. Tjeenk Willink, 1990), pp. 84-97.
6 Special reference should be made here to the milestone report of the Health Council
of the Netherlands, Heredity: Science and Society; on the possibilities and limits ofgenetic testing and
gene therapy (The Hague, Health Council of the Netherlands, 1989; publication no. 89/31),
a report that was prepared by a committee chaired by Roscam Abbing. In the 1990s she
sought, once again, as advisor to the Minister of Health, attention for the impact of genet-
ics inside and outside the health care sector, resulting in the policy paper 'The Application
of Genetics in the Health Care Sector', submitted to Parliament on 5 December 2000
(Kamerstukken II 2000/01, 27 543, nr. 1-2).
7 I. Berlin, Two Concepts ofliberry (Oxford, Oxford University Press, 1958), p. 7.
8 Cf. according to the case law of the Strasbourg organs Article 8 ECHR secures to
the individual a sphere within which he or she can freely pursue the development and
fulfilment of his or her personality (see e.g. Briiggeman and Scheuten v. Germany, Appl, no.
6959/75, Commission's report of 12 July 1977, Decisions and Reports 10, p. 115, § 55).
9 H.D.C. Roscam Abbing, Beslissen door de patient (Houten/Zaventem, Bohn Stafleu Van
Loghum, 1994).
10 ECHR 4 January 2005 (dec.), Pentiacova et al. v. Moldova, EHRC 2005, 33, with a com-
mentary by A.C. Hendriks.
II H.D.C. Roscam Abbing, 'Solidariteit en individuele gebondenheid: vrijheid in gebon-
denheid', Preadviezen ;:'or£ schaarste en recht (Utrecht, Vereniging voor gezondheidsrecht,
2002), pp. 1-35.
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rights as equally important for the protection of human dignity, with equal-
ity often serving as "a bridge (as well as an independent right)." Roscam
Abbing can be seen as a contemporary French revolutionary trying to find
a proper balance between these fundamental principles both inside and
outside the health care sector.
Attempts to harmonise liberty, equality and solidarity can also be detected
when studying the European Convention on Human Rights and Biomedicine
(Biomedicine Convention)." As with most other human rights instruments,
the Convention does not merely bestow rights and freedoms on 'all human
beings' (Article 1) and 'everyone' (Article 10), but also endeavours to uphold
the principles of equality (Article 3)14 and non-discrimination (Article 11),
and contains provisions granting additional protection to especially vulnerable
groups, such as people unable to consent (Article 6), persons with a men-
tal disorder (Article 7) and research subjects unable to consent (Article 17).
According to Article 11 of the Biomedicine Convention 'Any form of
discrimination against a person on grounds of his or her genetic heritage
is forbidden.' The meaning of this non-discrimination clause is not par-
ticularly clear. This is also a major reason why Roscam Abbing was dis-
appointed about this provision, the other one being that Article 11 fails
to provide proper protection against the discriminatory use of genetic infor-
mation by insurance companies and employers." Since other health and
human rights scholars have almost systematically neglected this provision,
it remains uncertain to what extent Roscam Abbing's anxiety about the
(lack of) safeguards offered by Article 11 of the Biomedicine Convention
against genetic discrimination was well founded.
In this contribution I will assess the protection guaranteed by the
Biomedicine Convention against genetic discrimination. This requires, first
of all, providing clarity about the meaning of the terms 'discrimination'
(section 2) and 'genetic discrimination' (section 3). In articulating the meaning
of these concepts particular attention will be paid to the standards set by
the European Convention on Human Rights (ECHR)16 and the jurisprudence
of the ECtHR now that the Biomedicine Convention was meant to elab-
12 Cf. Vienna Declaration and Programme ofAction--Final document of the World Conference on
Human Rights (Vienna, 14-25 June 1993), UN Doc. A/CONF.l57/23.
13 Convention on Human Rights and Biomedicine, Oviedo, 4 April 1997, ETS 164.
14 Although this provision refers to 'equitable access to health care'.
15 H.D.C. Roscam Abbing, 'The Convention on Human Rights and Biomedicine. An
Appraisal of the Council of Europe Convention', 5 European journal if Health Law 4- I998,
pp. 377-387 (383).
16 Convention for the protection of Human Rights and Fundamental Freedoms, Rome,
4 November 1950, ETS 5.
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orate some of the principles enshrined in the ECHR and seeks to offer
additional protection for the human person in the context of the devel-
opment of biomedical sciences and their application." Subsequently, I will-
building on the previous sections-examine the object and purpose of
Article 11 of the Biomedicine Convention (section 4), followed by an
appraisal (section 5) and, finally, I draw some conclusions (section 6).
2. Discrimination
The prohibition of discrimination is the counterpart of the principle of
equality. It prohibits the adverse treatment of persons on grounds that are
intimately related to human dignity. The latter concept underlies all human
rights," including the rights protected by the Biomedicine Convention,19
and is also recognized as a general principle of law under Community
law.20
The connection between equality and human dignity reflects the idea
that discrimination should be distinguished from arbitrary or otherwise
unjustified forms of unequal treatment adversely effecting a person or group.
The grounds protected by the principle of non-discrimination are there-
fore, by definition, rather exclusive, all having an immediate link with
human dignity. Grounds protected by human rights instruments, such as
the ECHR, include such personal criteria as sex, race, colour, language,
religion, political or other opinion, national or social origin, association
with a national minority, property and birth."
Article 14 of the ECHR, which prohibits discrimination, contains a non-
exhaustive list of covered grounds. This means that persons who feel that
they have been discriminated against on a non-enumerated ground can
also claim protection under Article 14. At the same time, it should be
noted that Article 14 is not framed in general terms of equality before the
law or equal protection under the law, but merely guarantees everyone
within the jurisdiction of a State party to the ECHR the equal enjoyment
17 Explanatory Report to the Convention on Human Rights and Biomedicine, Strasbourg,
Council of Europe, May 1997, Dir/jur (97)5.
18 ECtHR 9 March 2004, Glass v. UK, .NJ 2005, 14, EHRC 2004, 38, with a commen-
tary by A.C. Hendriks and ECtHR 8 July 2004, Va v. France, EHRC 2004, 86, with a com-
mentary by A.C. Hendriks & J.A. Bomhoff, both being cases where the Court referred to
the Biomedicine Convention.
19 Article 1 § 1.
20 Court of Justice of the EC 14 October 2004, case C-36/02 (Omega), Jur. 2004, EHRC
2004, 103, with a commenatary by J.H. Gerards, § 34.
21 Article 14 ECHR.
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of the rights and freedoms protected by the Convention. Or, to phrase it
differently, Article t"4 does not contain an independent right to equality
or non-discrimination, but has an accessory nature now that its meaning
is confined to rights and freedoms set forth in the ECHR and the addi-
tional protocols theroto.
Through the adoption of Protocol XII to the ECHR, the meaning of
the prohibition of non-discrimination under the ECHR has changed, now
that is has obtained the status of an independent right. 22 Accordingly, it
is no longer necessary that a complaint falls within the ambit of a sub-
stantive Convention right before a plaintiff can invoke the right not to be
discriminated against." The list of explicitly mentioned grounds and the
non-exhaustive nature thereof enshrined in this catalogue remained
unchanged. As a result, Protocol XII offers more ample protection against
discrimination, although-different from the Biomedicine Convention-no
reference is made to genetic heritage or-as in the case of Article 21 of
the Charter of Fundamental Rights of the European Union24-to genetic
features.
Discrimination commonly entails making a comparison. This also holds
true with respect to the case law of the ECtHR. According to the initial
jurisprudence of the Court the prohibition of discrimination was violated
in the case of a detrimental distinction that had no objective and reasonable
justification." This presupposes similar situations," analogous situations"
or relevantly similar situations.I" At a later stage the Court acknowledged
that discrimination could also occur when States, without an objective and
reasonable justification, fail to treat differently persons whose situations are
22 Protocol XII to the Convention for the protection of Human Rights and Fundamental
Freedoms, Rome, 4 November 2000, ETS 177.
23 Here it should be noted that the Court has interpreted Convention rights rather
broadly. E.g. although the Convention does not proclaim a right to work, the Court has
repeatedly held that discrimination with respect to employment contradicts Article 8 in
conjunction with Article 14. ECtHR 27 July 2004, Sidabras & Dziautas v. lithuania, EHRC
2004, 90, with a commentary by J.H. Gerards, and ECtHR 7 April 2005, Rainys &
Gasparaviiius v. lithuania, Appl.nos. 70665/01 & 74345/01.
24 Charter of Fundamental Rights of the European Union, Nice, 8 December 2000, OJ
2000, C 364/1.
25 ECtHR 22 July 1968, Case relating to certain aspects ofthe laws on the use oflanguages in
education in Belgium, Series A, n. 6, § 7.
26 ECtHR 13 June 1979, Marckx v. Belgium, Series A, n. 31, .N] 1980, 462, with a com-
mentary by E.A. Alkema, § 32 and ECtHR 28 October 1987, Inre v. Austria, Series A,
n. 126,.N] 1989, 661, with a commentary by E.A. Alkema, .N]CM-Bulletin 1988, p. 242,
with a commentary by J. de Boer, § 41.
27 ECtHR 28 November 1984, Rasmussen v. Denmark, Series A, n. 87, .N] 1986, 4, with
a commentary by E.A. Alkema & E.A.A. Luijten, § 35.
28 ECtHR 18 February 1991, Fredin v. Sweden, Series A, n. 192, § 60.
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significantly different." More recently, the Court seemed inclined to recog-
nise that the prohibition of discrimination not only applies to direct dis-
crimination, but also to indirect discrimination." In addition, the Court
has meanwhile also found that certain pejorative forms of treatment do as
such violate the principles of equality and non-discrimination, independent
of the treatment which a comparator receives." It follows that the Court,
starting with a formal approach towards the principle of equality, nowa-
days interprets the prohibition of discrimination in a more substantive way,
thus taking differences into account. The latter is important, now that peo-
ple, due to their (predictive) health status, often do find themselves in a
'different situation' and are prone to forms of exclusion and the denial of
unequal opportunities which others will never be confronted with (below,
under section 5).
From the jurisprudence of the ECtHR it can also be seen that the Court
has, referring to the fact that the Convention is a living instrument that
must be interpreted in present-day conditions.F frequently made use of the
non-exhaustive character of the non-discrimination provision in the
Convention to offer protection against discrimination on non-listed grounds,
such as nationality." being born within or outside marriage" and sexual
orientation." which are so intimately related to human dignity that adverse
treatment on these grounds constitutes discrimination.
On the basis of the case law of the ECtHR it can be concluded that
Article 14 of ECHR and Protocol XII to the ECHR prohibit the unjustified
different treatment of persons who find themselves in equal situations as
well as the unjustified equal treatment of persons who find themselves in
different situations on grounds intimately related to human dignity. The
29 ECtHR 6 April 2000, Thlimmenos u. Greece (GC), AB 2000, 386, with a commentary
by L.F.M. Verhey, EHRC 2000, 45,with a commentary by J.H. Gerards, .N]CM-Bulletin
2000, p. 1095, with a commentary by A.C. Hendriks & T. Loenen, RN 2000, 1245, with
a commentary by R.A. Lawson, § 44.
30 ECtHR 6 January 2005, Hoogendijk u. the Netherlands (dec.), EHRC 2005, 24, with a
commentary by J.H. Gerards, J(jCM-Bulletin 2005, with a commentary by A.C. Hendriks,
USZ 2005, with a commentary by M. Driessen.
31 ECtHR 26 February 2004, Nachooa et al. u. Bulgaria, J(jCM-Bulletin 2004, p. 1153, with
a commentary by D. Houtzager, EHRC 2004, 35, with a commentary by K. Henrard.
32 ECtHR 25 April 1978, Tyrer v. the UK, Series A, no. 26, § 31.
33 ECtHR 16 September 1996, Gl!Ygusuz v. Austria, R]D I996-IV, No. 14, p. 1129, .N]
1998, 738, AB 1997, 179, with a commentary by FJ.L. Pennings, .N]CM-Bulletin 1997,
p. 461, with a commentary by C.A. Groenendijk, § 42.
34 ECtHR 13June 1979, March u. Belgium, Series A, n. 31, .N] 1980, 462, with a com-
mentary by E.A. Alkema.
35 ECtHR 21 December 1999, Salgueiro da Silva Mouta v. Portugal, .N] 2001, 271, EHRC
2000, 16, with a commentary by].H. Gerards, .N]CM-Bulletin 2000, p. 880, with a com-
mentary by Cl Forder.
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prohibition of non-discrimination also sets minimum standards to protect
essential aspects of human dignity. Despite the accessory nature of Article
14, legal protection against discrimination extends to various areas which
are essential for the development and fulfilment of an individual's person-
ality. It was furthermore noticed that the Court nowadays applies the prin-
ciple of non-discrimination in a non-formal, substantive way, an approach
which allows individuals to challenge dominant standards and to demand
measures to accommodate differences.
3. Genetic Discrimination
The term 'genetic discrimination' was coined to refer to unfair adverse
treatment on the basis of a person's genetic constitution that has not (yet)
led to expression. Although differentiation on the basis of hereditary fac-
tors has always taken place in human history, it was felt that progress in
the field of human genetics enhanced the risk of (groups of) individuals
being unjustifiably denied equal opportunities on the basis of inherited
characteristics that are known or thought to be related with a predisposi-
tion to a genetic disease, a susceptibility to a genetic disorder or otherwise
associated with genetically determined morbidity and mortality. There was
(and is) particular concern about the use of genetic information as a tool
to identify and exclude 'high risk' individuals from employment and pri-
vate insurance, not only because of doubts about the legal and ethical
acceptability and effectiveness," but also now that it might undermine the
legitimacy of genetic research."
However, what is precisely meant by 'genetic discrimination'? Upon
closer scrutiny it becomes clear that this term is used in various ways.
Taylor distinguishes three forms of genetic discrimination." First, discrimina-
tion on the basis of genetic information derived from genetic data. Second,
discrimination on the basis of genetic information not derived from genetic
data, but on certain conditions that correspond with a particular genetic
make-up. Third, discrimination on grounds of a particular characteristic
that is disproportionately associated with a particular genetic variation.
36 K.T. Palmer et al., 'Quantifying the Advantages and Disadvantages of Pre-Placement
Genetic Testing', 61 Occup Environ Medicine 2004, pp. 448-453.
37 C( the proposed US Genetic Information Nondiscrimination Act. A Bill was passed
by US Senate on 17 February 2005.
38 MJ. Taylor, 'Problems of Practice and Principle if Centring Law Reform on the
Concept of Genetic Discrimination', II European Journal qf Health Law 4-2004, pp. 365-380.
214 AART HENDRIKS
Taylor adds that these forms of genetic discrimination are not mutually
exclusive but can-and quite often do-reinforce each other.
Underlying these distinctions is uncertainty about the meaning of the
adjective 'genetic' in combination with the noun discrimination. Does genetic
refer to the human genome'" or genetic status.t" as a result of which genetic
discrimination would also cover adverse treatment on such grounds as sex,
race and (some forms of) disability? Or should the adjective genetic be
interpreted in a more restrictive way, linking it to information obtained
from genetically-based diagnostic and prognostic tests" or, even more
confined, connecting it with genetic information about an asymptomatic
personi'"
Elsewhere I have argued-together with others-that the aim of pro-
hibiting genetic discrimination is to protect individuals from being unjustifiably
denied equal opportunities on the basis of (real or assumed) information
about their genetic characteristics.P This goal-oriented approach seeks to
ensure that a prohibition of genetic discrimination can adequately respond
to problems that may (and sometimes already do) emerge as a result of
progress in the field of genetics, and which are not already addressed by
existing non-discrimination laws and rules. In this way, the introduction of
a prohibition of genetic discrimination will complement the applicable non-
discrimination standards and has, from a human rights perspective, added
value.
Although there is as yet no universal consensus about the meaning of
'genetic discrimination' it seems logical to reserve this term for forms of
unjustified adverse treatment on the basis of information about one's genetic
characteristics.«
39 P.R. Billings, et aI., 'Discrimination as a Consequence of Genetic Testing,' 50 American
Journallif Human Genetics 1992, pp. 476-482 (477).
40 M.A. Rothstein, 'Genetic Discrimination in Employment: Ethics, Policy and Comparative
law', in: Swiss Institute of Comparative Law (eds.), Human Genetic Analysis and the Protection
ofPersonali!J and Privacy (Zurich, Schulthess, 1994), p. 129.
41 L. Gostin, 'Genetic Discrimination: the Use of genetically based Diagnostic and
Prognostic Tests by Employers and Insurers', 17 American Journal ofLaw and Medicine 1991,
pp. 109-144
42 M.S. Yesley, 'Protecting Genetic Difference', 13 Berkell!J Technology Law Journal 1998,
pp. 653-672.
43 A.C. Hendriks & J.K.M. Gevers, Juridische bescherming tegen ongerechtvaardigd
gebruik van genetische informatie buiten de gezondheidszorg', 29 .N]CM-Bulletin 8-2004,
pp. 1114-1130 and J.K.M. Gevers, A.C. Hendriks et aI., Bescherming tegen genetische discrim-
inatie. Een juridische analyse (Leiden, Stichting NJCM-Boekerij, 2004).
44 This description does not apply a value judgement with respect to the distinction made
between genetic and non-genetic health information (also known under the name 'genetic
exceptionalism'), an issue that I will not further embark upon in this contribution. For an
extensive analysis of the term genetic discrimination from a comparative perspective, see
J.H. Gerards, A.W. Heringa & H.L. Janssen, Genetic Discrimination and Genetic Pruiacy in a
Comparative Perspective, Antwerp: Intersentia 2005.
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As mentioned before, Article 11 of the Biomedicine Convention prohibits
'any form of discrimination against a person on grounds of his or her
genetic heritage.' The reason to include this provision reflects 'concern that
genetic testing, which can detect a genetic disease, predisposition or a
susceptibility to a genetic disease, may become a means of selection and
discrimination. '45
From the Explanatory Report it becomes clear that the meaning of the
prohibition of discrimination in Article 11 of the Biomedicine Convention
should be understood with reference to the case law of the ECtHR with
respect to Article 14 of the ECHR.46 It follows that both provisions should
be interpreted and applied identically.
Surprisingly, the Explanatory Report fails to elaborate on the meaning
of 'genetic heritage'. In fact, the report merely stipulates that 'the funda-
mental principle established by Article 11 is that any form of discrimina-
tion against an individual on grounds of his or her genetic heritage is
prohibited. '47 A document prepared by the Secretariat of the Council of
Europe's Steering Committee on Bioethics (CDBI), under the title 'Preparatory
Work on the Convention', neither explains the meaning of 'genetic her-
itage' nor provides a rationale for embracing this term." From this report,
one gets the impression that the discussion in the preparatory phase above
all focussed on clarifying the meaning of 'discrimination', instead of 'genetic
(heritage)' .
It follows that Article 11 of the Biomedicine Convention, which pro-
hibits discrimination on grounds of 'genetic heritage', should be interpreted
in conformity with the general goals of the Biomedicine Convention, that
is to say to complement the protection already offered by the ECHR geared
towards human rights problems that may emerge as a result of advances
in medicine and biology. Although one could argue that the term 'genetic
heritage' lacks precision and is also otherwise inaccurate, it is abundantly
clear that the intention has been to expand the scope of Article 14 of the
ECHR to guarantee that individuals enjoy protection against unjustified
adverse treatment on grounds of (information concerning) genetic charac-
teristics that are not yet (explicitly) covered by Article 14 of the ECHR.
45 Explanatory Report to the Convention on Human Rights and Biomedicine, Strasbourg,
Council of Europe, May 1997, Dir/jur (97)5, § 74
46 Ibidem, § 76.
47 Ibidem, § 75.
48 CDBI, Preparatory Work on the Convention, Strasbourg, Council of Europe, June
2000, CDBI/INF (2000) 1, pp. 52-53.
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5. Appraisal
If one accepts that developments in science and their application both
within and outside the field of health care may have adverse effects on
the equal opportunities of those with inherited characteristics that are known
or thought to be related to a predisposition to a genetic disease, a sus-
ceptibility to a genetic disorder or otherwise associated with genetically
determined morbidity and mortality, then the inclusion of Article 11 in
the Biomedicine Convention should be welcomed. This holds particularly
true now that Article 14 of the ECHR does not explicitly refer to (infor-
mation concerning) genetic characteristics and the ECtHR has so far never
addressed the issue of genetic discrimination. Against this background Article
11 of the Biomedicine Convention may reinforce legal protection against
genetic discrimination. Still, one can question whether this provision offers
sufficient protection against genetic discrimination. These doubts stem from
(1) the complex (legal) nature of genetic discrimination, (2) the limited scope
of the prohibition of discrimination under Article 14 of the ECHR and
Protocol XII to the ECHR, and thus Article 11 of the Biomedicine
Convention, and (3) the weak enforcement mechanism established under
the Biomedicine Convention.
With respect to the nature of genetic discrimination, it should be recalled
that generic discrimination is different from most other forms of discrimi-
nation now that it refers to people who are being denied equal opportu-
nities on the basis of an (assumed) future risk that has not (yet) expressed
itself: In other words, at present they are not substantially different from
their comparator but as a result of hereditary factors a difference mayor
will occur in the future. Due to the latter, and the uncertainty about the
predictability of most genetic factors, genetic discrimination is as much an
issue of genetic privacy as of non-discrimination law. The fight against
genetic discrimination very much depends on safeguards against the unau-
thorised use and disclosure of privacy-related information. Offering adequate
protection against unjustifiable adverse treatment on the basis of (infor-
mation concerning) genetic characteristics therefore requires a concerted
and comprehensive privacy/non-discrimination approach, to avoid the sit-
uation where the protection offered by one body of law can be under-
mined by weaknesses in the other body of law and vice versa. Although
the Biomedicine Convention also protects the 'right to respect for private
life in relation to information about his or her health' (Article 10), nothing
in the text of the Convention and its Explanatory Report suggests that
both provisions should be read in conjunction to tackle genetic discrimination.
Although State laws and administrative practices can amount to genetic
discrimination, the call for protection against genetic discrimination notably
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emerged in response to concern about discriminatory practices by employers
and private insurers. This raises the question to what extent, if at all, the
prohibition of discrimination as enshrined in Article 14 of the ECHR and
Article 11 of the Biomedicine Convention requires States to outlaw dis-
crimination in the private sector. Here it should be recalled that the
Biomedicine Convention, just as other human rights treaties, above all
seeks to regulate the relations between the State and individuals (vertical
relations). Although conventions may also have an impact on horizontal
relations, this is hardly ever their primary objective. This also holds true
with respect to Protocol XII to the ECHR, where it is stipulated that 'No
one shall be discriminated against by any public authority ...' (Article I
para. 2; italics added-AH). From the Explanatory Report to the Protocol
it can be seen that 'Th[is] Article is not intended to impose a general pos-
itive obligation on the Parties to take measures to prevent or remedy all
instances of discrimination in relations between private persons. '4:9 Now that
Article 11 of the Biomedicine Convention should be applied in the same
way as Article 14 of the ECHR and, as can be assumed, Protocol XII to
the ECHR, it follows that States are allowed to address genetic discrimi-
nation in the private sector but are not required to do so. This can have
far-reaching consequences now that many States are in the process of pri-
vatising public services and social insurances. This would mean that, once
privatised, there is no longer a duty to offer protection against (genetic)
discrimination. With respect to the latter, it should be noticed that the
Biomedicine Convention in fact only contains a duty to 'provide appro-
priate judicial protection' against the unjustifiable infringements-presum-
ably by State agents-of rights and principles set forth in the Biomedicine
Convention (Article 23) and to provide for 'appropriate sanctions to be
applied in the event of infringement' of a Convention right (Article 25).
The protection offered by the Biomedicine Convention is thus insufficient
to adequately tackle genetic discrimination.
A third weakness of the Biomedicine Convention, also backlashing on
the protection against discrimination, concerns its weak enforcement mech-
anism. The Convention does not foresee a right for individuals to petition
the ECtHR or any other independent authoritative international body in
case of an alleged violation of Article 11. The Convention merely foresees
the possibility of 'advisory opinions' by the ECtHR (Article 29) and a mon-
itoring role by the Secretary General of the Council of Europe, who is
49 Explanatory Report to Protocol No. 12 to the Convention for the Protection of Human
Rights and Fundamental Freedoms, Strasbourg, Council of Europe, [http:/I conventions.coe.intl
Treaty/EN/Reports/HtmIl177.htm] § 25.
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entitled to ask States parties to furnish a report on compliance with the
Convention (Article 30).
6. Conclusions
Roscam Abbing was right to conclude that Article 11 of the Biomedicine
Convention contains various flaws that weaken its potential to serve as a
powerful legal basis to outlaw and eliminate genetic discrimination in the
States parties to this convention. This does not make this provision redun-
dant. Genetic discrimination is increasingly perceived as a threat to human
rights, thus calling upon legislators and policy makers to take appropriate
measures. In obliging States parties to forbid discrimination on grounds of
genetic heritage, Article 11 of the Biomedicine Convention conveys an
important message that ~an be used as a tool to discuss law and policy
reform measures.
It was argued here that it is relatively easy to overcome the conceptual
unclarity surrounding the term 'genetic heritage'. Now that Article 11 of
the Biomedicine Convention seeks to complement the protection offered
by Article 14 of the ECHR and Protocol XII to the ECHR it appears
logical to interpret this term as meaning information about one's genetic
characteristics.
Admittedly, Article 11 of the Biomedicine Convention, in its present
form, offers as such an insufficient basis to adequately tackle (prospective)
genetic discrimination, notably in those fields where legal protection is
probably most needed. These weaknesses were attributed to the interrela-
tionship between genetic privacy and genetic discrimination, which call for
concerted action, the fact that human rights law, including the Biomedicine
Convention, above all seeks to regulate the relations between the State and
individuals whereas genetic discrimination is above all feared to threaten
freedom, equality and solidarity in horizontal relations, and the weak
enforcement mechanism established under the Biomedicine Convention.
The above shortcomings should not deter States from using Article 11
of the Biomedicine Convention as an incentive and vehicle to introduce
the necessary legal and policy measures to prevent and prohibit genetic
discrimination. This is not to deny that Roscam Abbing's visionary exper-
tise will be particularly and sadly missed with respect to the formulation
and design of measures like these. Her written work contains a goldmine
of information and inspiration from which the coming generation of health
and human rights lawyers can gratefully benefit, also with respect to issues
as discussed in this contribution.
